Resection of pancreatic cancer in Europe and USA: an international large-scale study highlighting large variations
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Objective: Resection can potentially cure resectable pancreatic cancer (PaC) and significantly prolong survival in some patients. This large-scale international study aimed to investigate variations in resection for PaC in Europe and USA and determinants for its utilisation. Design: Data from six European population-based cancer registries and the US Surveillance, Epidemiology, and End Results Program database during 2003–2016 were analysed. Age-standardised resection rates for overall and stage I–II PaCs were computed. Associations between resection and demographic and clinical parameters were assessed using multivariable logistic regression models. Results: A total of 153 698 records were analysed. In population-based registries in 2012–2014, resection rates ranged from 13.2% (Estonia) to 21.2% (Slovenia) overall and from 34.8% (Norway) to 68.7% (Denmark) for stage I–II tumours, with great international variations. During 2003–2014, resection rates only increased in USA, the Netherlands and Denmark. Resection was significantly less frequently performed with more advanced tumour stage (ORs for stage III and IV versus stage I–II tumours: 0.05–0.18 and 0.01–0.06 across countries) and increasing age (ORs for patients 70–79 and ≥80 versus those <60 years: 0.37–0.63 and 0.03–0.16 across countries). Patients with advanced-stage tumours (stage III–IV: 63.8%–81.2%) and at older ages (≥70 years: 52.6%–59.5%) receiving less frequently resection comprised the majority of diagnosed cases. Patient performance status, tumour location and size were also associated with resection application. Conclusion: Rates of PaC resection remain low in Europe and USA with great international variations. Further studies are warranted to explore reasons for these variations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Conroy, T., Desseigne, F., Ychou, M., Bouché, O., Guimbaud, R., Bécouarn, Y., Adenis, A., Raoul, J.-L., Gourgou-Bourgade, S., de la Fouchardière, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1011923 · Cited by 7,810
Moons, K. G. M., Altman, D. G., Reitsma, J. B., Ioannidis, J. P. A., Macaskill, P., Steyerberg, E. W., Vickers, A. J., Ransohoff, D. F., & Collins, G. S. (2015) · Annals of Internal Medicine · doi:10.7326/m14-0698 · Cited by 5,147
Ryan, D. P., Hong, T. S., & Bardeesy, N. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1404198 · Cited by 2,348
Canto, M. I., Harinck, F., Hruban, R. H., Offerhaus, G. J., Poley, J.-W., Kamel, I., Nio, Y., Schulick, R. S., Bassi, C., Kluijt, I., et al. (2013) · Gut · doi:10.1136/gutjnl-2012-303108 · Cited by 784
Research works printed but not linked: 43
- 10.3322/caac.21262 · DOI · Paper page
- 10.1093/annonc/mdw022 · DOI · Paper page
- 10.3322/caac.21190 · DOI · Paper page
- 10.1093/annonc/mdv295 · DOI · Paper page
- 10.6004/jnccn.2014.0106 · DOI · Paper page
- 10.1200/JCO.2016.67.1412 · DOI · Paper page
- 10.1200/JCO.2016.67.5553 · DOI · Paper page
- 10.1200/JCO.2016.67.5561 · DOI · Paper page
- 10.1001/jama.2013.279201 · DOI · Paper page
- Nimptsch, 2016, Nationwide in-hospital mortality following pancreatic surgery in Germany is higher than anticipated, Ann Surg, 264, 1082, 10.1097/SLA.0000000000001693 · DOI
- Krautz C , Nimptsch U , Weber GF , et al . Effect of Hospital Volume on In-hospital Morbidity and Mortality Following Pancreatic Surgery in Germany. Ann Surg 2017:1.doi:10.1097/SLA.0000000000002248 · DOI · Paper page
- Ceppa, 2015, Reducing readmissions after pancreatectomy: limiting complications and coordinating the care continuum, J Am Coll Surg, 221, 708, 10.1016/j.jamcollsurg.2015.05.012 · doi:10.1016/j.jamcollsurg.2015.05.012
- 10.1002/bjs.8664 · DOI · Paper page
- 10.1002/bjs.7581 · DOI
- 10.1002/bjs.9468 · DOI · Paper page
- van der Geest, 2016, Pancreatic cancer surgery in elderly patients: Balancing between short-term harm and long-term benefit. A population-based study in the Netherlands, Acta Oncol, 55, 278, 10.3109/0284186X.2015.1105381 · doi:10.3109/0284186x.2015.1105381
- Cronin-Fenton, 2011, Pancreatic cancer survival in central and northern Denmark from 1998 through 2009: a population-based cohort study, Clin Epidemiol, 3, 19, 10.2147/CLEP.S20611 · DOI
- Onete, 2015, Impact of centralization of pancreatoduodenectomy on reported radical resections rates in a nationwide pathology database, HPB, 17, 736, 10.1111/hpb.12425 · DOI
- van der Geest, 2016, Volume-outcome relationships in pancreatoduodenectomy for cancer, HPB, 18, 317, 10.1016/j.hpb.2016.01.515 · DOI
- 10.1245/s10434-010-1511-4 · DOI
- O’Mahoney, 2016, Centralization of pancreatoduodenectomy a decade later: Impact of the volume-outcome relationship, Surgery, 159, 1528, 10.1016/j.surg.2016.01.008 · doi:10.1016/j.surg.2016.01.008
- Ryan, 2015, Pancreaticoduodenectomy in Florida: do 20-year trends document the salutary benefits of centralization of care?, HPB, 17, 832, 10.1111/hpb.12467 · doi:10.1111/hpb.12467
- 10.1002/bjs.5861 · doi:10.1002/bjs.5861
- Ahola, 2017, Effect of centralization on long-term survival after resection of pancreatic ductal adenocarcinoma, Br J Surg, 104, 1532, 10.1002/bjs.10560 · doi:10.1002/bjs.10560
- 10.1007/s00268-013-2108-4 · DOI
- 10.1245/s10434-014-4036-4 · DOI · Paper page
- Kim, 2016, Improved survival after palliative resection of unsuspected stage IV pancreatic ductal adenocarcinoma, HPB, 18, 325, 10.1016/j.hpb.2015.10.014 · doi:10.1016/j.hpb.2015.10.014
- 10.1016/S1470-2045(13)70172-4 · DOI · Paper page
- 10.1245/s10434-013-2886-9 · DOI · Paper page
- 10.1016/j.surg.2014.02.001 · DOI · Paper page
- 10.6004/jnccn.2017.0131 · DOI · Paper page
- 10.1097/SLA.0000000000000263 · DOI · Paper page
- Sukharamwala, 2012, Advanced age is a risk factor for post-operative complications and mortality after a pancreaticoduodenectomy: a meta-analysis and systematic review, HPB, 14, 649, 10.1111/j.1477-2574.2012.00506.x · DOI · Paper page
- He, 2015, Underuse of surgical resection among elderly patients with early-stage pancreatic cancer, Surgery, 158, 1226, 10.1016/j.surg.2015.04.031 · doi:10.1016/j.surg.2015.04.031
- Marmor, 2016, A comparative analysis of survival outcomes between pancreatectomy and chemotherapy for elderly patients with adenocarcinoma of the pancreas, Cancer, 122, 3378, 10.1002/cncr.30199 · doi:10.1002/cncr.30199
- 10.1111/j.1532-5415.2011.03785.x · doi:10.1111/j.1532-5415.2011.03785.x
- 10.1001/archsurg.2011.294 · DOI
- Cameron, 2015, Two thousand consecutive pancreaticoduodenectomies, J Am Coll Surg, 220, 530, 10.1016/j.jamcollsurg.2014.12.031 · DOI · Paper page
- Heerkens, 2016, Health-related quality of life after pancreatic resection for malignancy, Br J Surg, 103, 257, 10.1002/bjs.10032 · DOI
- Laitinen, 2017, Quality of life in patients with pancreatic ductal adenocarcinoma undergoing pancreaticoduodenectomy, Pancreatology, 17, 445, 10.1016/j.pan.2017.02.013 · doi:10.1016/j.pan.2017.02.013
- 10.1093/annonc/mdt193 · DOI
- Minicozzi, 2017, Quality analysis of population-based information on cancer stage at diagnosis across Europe, with presentation of stage-specific cancer survival estimates: A EUROCARE-5 study, Eur J Cancer, 84, 335, 10.1016/j.ejca.2017.07.015 · doi:10.1016/j.ejca.2017.07.015
- van Rijssen, 2016, National compliance to an evidence-based multidisciplinary guideline on pancreatic and periampullary carcinoma, Pancreatology, 16, 133, 10.1016/j.pan.2015.10.002 · doi:10.1016/j.pan.2015.10.002
Cited by
Optimizing the outcomes of pancreatic cancer surgery
Strobel, O., Neoptolemos, J., Jäger, D., & Büchler, M. W. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0112-1 · Cited by 943
Self-citationStoop, T. F., Javed, A. A., Oba, A., Koerkamp, B. G., Seufferlein, T., Wilmink, J. W., & Besselink, M. G. (2025) · The Lancet · doi:10.1016/s0140-6736(25)00261-2 · Cited by 479
Self-citationMetabolism of pancreatic cancer: paving the way to better anticancer strategies
Qin, C., Yang, G., Yang, J., Ren, B., Wang, H., Chen, G., Zhao, F., You, L., Wang, W., & Zhao, Y. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01169-7 · Cited by 413
A one-pot isothermal Cas12-based assay for the sensitive detection of microRNAs
Yan, H., Wen, Y., Tian, Z., Hart, N., Han, S., Hughes, S. J., & Zeng, Y. (2023) · Nature Biomedical Engineering · doi:10.1038/s41551-023-01033-1 · Cited by 361
Blackford, A. L., Canto, M. I., Klein, A. P., Hruban, R. H., & Goggins, M. (2020) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djaa004 · Cited by 270
Metadata
- Authors
- Huang, L., Jansen, L., Balavarca, Y., Molina-Montes, E., Babaei, M., van der Geest, L., Lemmens, V., Van Eycken, L., De Schutter, H., Johannesen, T. B., Fristrup, C. W., Mortensen, M. B., Primic-Žakelj, M., Zadnik, V., Becker, N., Hackert, T., Mägi, M., Cassetti, T., Sassatelli, R., Grützmann, R., Merkel, S., Gonçalves, A. F., Bento, M. J., Hegyi, P., Lakatos, G., Szentesi, A., Moreau, M., van de Velde, T., Broeks, A., Sant, M., Minicozzi, P., Mazzaferro, V., Real, F. X., Carrato, A., Molero, X., Besselink, M. G., Malats, N., Büchler, M. W., Schrotz-King, P., & Brenner, H.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2017-11-20
- Volume
- 68
- Issue
- 1
- Pages
- 130-139
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2770675262
- Cited by
- 223
- References
- 4
- FWCI
- 6.35
- Type
- journal article
- Language
- en
- Open access
- green
- Funders
- Deutsche Krebshilfe
- Fondo de Investigaciones Sanitarias (FIS), Instituto de Salud Carlos III-FEDER, Spain
- European Cooperation in Science and Technology
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Resection of pancreatic cancer in Europe and USA: an international large-scale study highlighting large variations. https://app.cochat.ai/papers/10.1136/gutjnl-2017-314828
- The paper
- Huang, L., Jansen, L., Balavarca, Y., Molina-Montes, E., Babaei, M., van der Geest, L., Lemmens, V., Van Eycken, L., De Schutter, H., Johannesen, T. B., Fristrup, C. W., Mortensen, M. B., Primic-Žakelj, M., Zadnik, V., Becker, N., Hackert, T., Mägi, M., Cassetti, T., Sassatelli, R., . . . Brenner, H. (2019). Resection of pancreatic cancer in Europe and USA: an international large-scale study highlighting large variations. Gut. https://doi.org/10.1136/gutjnl-2017-314828
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.